Molecular Staging is addressing this demand with a portfolio of products and services based on technologies that are transforming the detection and measurement of both proteins and nucleic acids.
- The epigenetics of cancer, a recent view
- Structure of an enzyme and its in hibitor
- Rolling Circle Amplification Technology–Technical Details
- Human skin analysis
- Development and morphogenesis: potentialities from common patterns
- PROPERTIES OF DNA
- Induction therapy of autophagy and apoptosis in melanoma cells
- Cancer as a Disease of the Cell Cycle
- Tigar or how p53 controls glycolysis
- Molecular basis of interactions between integrin and plectina
- Parallel evolution of the venom of snakes and integrin
- The Molecular Biology of HIV/AIDS
- RCAT™—Research Reagents
- Molecular link between aging and cancer
- The mitofusin 2 in mitochondrial energization
The word “cancer” is terrifying to most of us because it carries with it images of doom. However, there is no one disease called “cancer” but rather a number of diseases that share a common feature: the growth of cells that have lost the ability to control the cell cycle. Some of these diseases are quite treatable, while others are much more difficult and are, in fact, life threatening and often terminal.
The commonality of the diseases has to do with the cell cycle itself, shown below with several of the key control points indicated: Read the rest of this entry »
This page was tagged:
The Nature of Viruses
The biosphere contains organisms that are, like ourselves, based upon cells. However, there are other forms of life around us. Among these are the viruses, defined as a cellular, obligate intracellular parasites.
I call them “acellular” because during their replication, they do not obey the cell theory. That is viruses do not arise from preexisting viruses by binary fission. I won’t go into the details of a viral replication cycle for the purposes of this course, except to tell you that the world of the viruses is quite a different place from our world. Read the rest of this entry »